ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    Phase 1b/2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Subjects with Severe Sepsis
Previous Study | Return to List | Next Study

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02576457
Recruitment Status : Terminated (Business Objectives Have Changed)
First Posted : October 15, 2015
Last Update Posted : September 15, 2017
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 15, 2017
  Actual Study Completion Date : March 15, 2017